STXBP1 and epilepsy: STXBP1, SYNGAP1, and WDR45, which are canonical epilepsy genes, were among the predicted targets, suggesting that tsRNAs may contribute to the broader molecular landscape underlying disease susceptibility (Zhang et al. 2024).